Drawing from his distinguished career in the pharmaceutical industry, Cerevel Therapeutics Chairman and former CEO Tony Coles discusses developments in biotechnology, the implications of health polic…

Tony Coles in conversation on his distinguished career in medicine and biotechnology, including his roles as CEO of Cerevel Therapeutics and chairman and founder of Yumanity Therapeutics where he was…

Panelists discuss new and emerging commercial defense technology, current opportunities and challenges in defense innovation, and the future landscape of national security. For those attending vir…

Eric Doucette, captain in the U.S. Coast Guard and visiting military fellow at CFR, discusses the primary missions of the coast guard including disaster management, protecting U.S. ports and shorelin…

Panelists discuss the trends revealed in this year’s AI Index Report, including technical advancements in AI, public perceptions of the technology, and the geopolitical dynamics surrounding its devel…

Aslı Aydıntaşbaş, visiting fellow in the Center on the United States and Europe at the Brookings Institution and senior policy fellow at the European Council on Foreign Relations, and Philip Gamaghel…

Over four billion people in more than three dozen countries will have the opportunity to vote for new leadership in elections in 2024. Panelists discuss the strength of democracies in the year ahead …

Panelists discuss private capital’s role in leading the clean energy transition and what it takes to establish a redeployment of steady capital investing in decarbonization. 

Panelists discuss potential and ongoing crises that may erupt or escalate in 2024, as well as their global political implications. This event will explore the results of CFR’s 2024 Preventive Priorit…